Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
04/03/2013 | CN103006898A Chinese medicament formula for treating osteoporosis |
04/03/2013 | CN103006894A Camphor rheumatism agent |
04/03/2013 | CN103006884A Chinese medicinal composition for treating osteoarthritis and preparation method thereof |
04/03/2013 | CN103006882A Traditional Chinese medicine for treating ONFH (osteonecrosis of femoral head) |
04/03/2013 | CN103006880A Preparation method of kidney tonifying and bone strengthening pill used for preventing and treating osteoporosis |
04/03/2013 | CN103006865A External medicament composition for treating arthritis |
04/03/2013 | CN103006861A External-use medicine for treating neck, shoulder, waist and leg diseases and osteoproliferation, and preparation method of medicine |
04/03/2013 | CN103006857A Medicinal composition for treating scapulohumeral periarthritis |
04/03/2013 | CN103006853A Traditional Chinese medicine for treating osteoporosis |
04/03/2013 | CN103006823A Bruise medicated wine and preparation method thereof |
04/03/2013 | CN103006817A Arthritis bath medicinal powder |
04/03/2013 | CN103006816A Formula of knee joint osteoarthritis treatment traditional Chinese medicine |
04/03/2013 | CN103006815A Traditional Chinese medicine external use film agent for treating pain diseases caused by rheumatoid bone diseases, cervical muscle and lumbar muscle degeneration, and scapulohumeral periarthritis |
04/03/2013 | CN103006782A Ficus auriculata extract and application thereof in preparation of medicine used for treating osteoporosis |
04/03/2013 | CN103006774A Externally applied powder for treating wind, cold, dampness and heat |
04/03/2013 | CN103006770A Chinese medicinal composition for treating rheumatism and rheumatoid |
04/03/2013 | CN103006763A Medicinal egg for treating arthritis and preparation method thereof |
04/03/2013 | CN103006755A Beggarweed extractive and general flavone and rhizoma kaempferiae glycosides separated from the beggarweed extractive and medical application thereof |
04/03/2013 | CN103006747A Application of ethyl acetate extract of celastrus orbiculatus stems in preparation of medicines for treating rheumatoid arthritis |
04/03/2013 | CN103006737A Oral liquid used for promoting blood circulation to remove meridian obstruction and preventing and treating osteoporosis |
04/03/2013 | CN103006732A Pharmaceutical composition for preventing ONFH (Osteonecrosis of Femoral Head) after child DDH (Developmental Dysplasia of Hip) operation |
04/03/2013 | CN103006712A Bee product extract with functions of resisting oxidation and eliminating free radicals |
04/03/2013 | CN103006693A Double-vitamin calcium carbonate composition |
04/03/2013 | CN103006645A Application of 2-aminobenzothiazole derivatives being taken as DHODH (dihydroorotate dehydrogenase) inhibitor |
04/03/2013 | CN103006570A Arzoxifene immediate-release pellets and preparation method thereof |
04/03/2013 | CN103006544A Preparation method of high-viscoelasticity sodium hyaluronate gel |
04/03/2013 | CN103006538A Ultrasonic microbubbles for treating arthritis and use thereof |
04/03/2013 | CN103006428A Ointment healthcare appliance and manufacturing method thereof |
04/03/2013 | CN102626382B Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection |
04/03/2013 | CN102416153B Medicament for treating rheumatic arthritis |
04/03/2013 | CN102363037B Externally applied plaster for treating rheumatism, rheumatoid arthritis and neck-shoulder and lumbocrural pain |
04/03/2013 | CN102343066B Medicinal composition for treating hyperosteogeny and preparation method thereof |
04/03/2013 | CN102343008B Chinese medicinal composition for treating prolapse of lumbar intervertebral disc |
04/03/2013 | CN102302585B Chinese medicinal composition for treating arthralgia syndrome |
04/03/2013 | CN102293977B Chinese medicinal composition for treating Bi syndrome, and preparation method and detection method of Chinese medicinal composition |
04/03/2013 | CN102266409B Medicinal composition for treating pain and preparation method thereof |
04/03/2013 | CN102258762B Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof |
04/03/2013 | CN102258633B Negundo chastetree fruit extract and application thereof |
04/03/2013 | CN102247423B External-use Chinese herbal medicine compound preparation for accelerating fracture healing |
04/03/2013 | CN102218095B Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine |
04/03/2013 | CN102172356B Use of taurochenodeoxycholic acid in prevention and treatment of osteoporosis |
04/03/2013 | CN102134225B Tricyclic diterpene lactone and preparation method and application thereof |
04/03/2013 | CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
04/03/2013 | CN102048893B Traditional Chinese medicine composition for treating arthromyodynia |
04/03/2013 | CN101878029B Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
04/03/2013 | CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof |
04/03/2013 | CN101759656B Febuxostat new crystal forms and preparation method thereof |
04/03/2013 | CN101631555B Prophylactic agent for autoimmune disease |
04/03/2013 | CN101417059B Ointment for treating burn and scald and preparation method thereof |
04/03/2013 | CN101374838B 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors |
04/02/2013 | US8410174 Method for treating arthritis |
04/02/2013 | US8410135 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
04/02/2013 | US8410059 CXCR4 antagonist and use thereof |
04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
04/02/2013 | CA2581110C Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
04/02/2013 | CA2532799C Human antibody molecules for il-13 |
04/02/2013 | CA2524603C Controlled release composition containing a strontium salt |
04/02/2013 | CA2503557C Osteogenesis promotor containing .beta.-cryptoxanthin as the active ingredient |
04/02/2013 | CA2472647C Mammal prolactin variants |
04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
03/29/2013 | CA2849336A1 Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
03/28/2013 | WO2013043840A1 Method for treating osteoporosis |
03/28/2013 | WO2013043529A1 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto |
03/28/2013 | WO2013042782A1 Condensed heterocyclic compound |
03/28/2013 | WO2013041502A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
03/28/2013 | WO2013041119A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
03/28/2013 | WO2013040649A1 Therapeutics using adipose cells and cell secretions |
03/28/2013 | WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
03/28/2013 | WO2012165900A3 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
03/28/2013 | US20130079337 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
03/28/2013 | US20130079317 Methods for treatment of diseases |
03/28/2013 | US20130078312 Biodegradable Putty Compositions and Implant Devices, Methods, and Kits Relating to the Same |
03/28/2013 | US20130078311 Composition for treating and/or preventing osteoporosis |
03/28/2013 | US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents |
03/28/2013 | US20130078237 Cd27l antigen binding proteins |
03/28/2013 | CA2849357A1 Acyclic cyanoethylpyrazoles as janus kinase inhibitors |
03/28/2013 | CA2848512A1 Method for treating osteoporosis |
03/28/2013 | CA2846369A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals |
03/27/2013 | EP2572721A1 Pharmaceutical composition including an hif-2 inhibitor as an active ingredient for preventing or treating arthritis |
03/27/2013 | EP2572719A1 Use of poloxamines as inducers of the osteogenic differentiation of mesenchymal cells |
03/27/2013 | EP2571988A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
03/27/2013 | EP2571881A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
03/27/2013 | EP2571532A2 Il-1 binding proteins |
03/27/2013 | CN202820613U Novel cervical vertebra medicine pillow |
03/27/2013 | CN202819713U Medicine type half-circular kneepad |
03/27/2013 | CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
03/27/2013 | CN1671391B Novel methods and compositions for alleviating pain |
03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
03/27/2013 | CN103002892A Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients |
03/27/2013 | CN103002886A Treatment of osteoporosis |
03/27/2013 | CN102994349A Production process of health-care tonic wine |
03/27/2013 | CN102994324A Fresh bamboo juice liquor and its production method |
03/27/2013 | CN102993289A Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof |
03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
03/27/2013 | CN102988984A Aqueous drug preparation of anti-TNF (tumor necrosis factor)-alpha human monoclonal antibody for strengthening stability |